Pharma-Bio Serv (PBSV) Capital Expenditures (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Capital Expenditures came in at $2321.0 in Q2 2026, down 45.49% YoY from $4258.0 in Q2 2025, and down 3.73% on a QoQ basis from $2411.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Capital Expenditures (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has 17 years of Capital Expenditures data on file, last reported at $2321.0 in Q2 2026.
- Quarterly Capital Expenditures fell 45.49% year-over-year to $2321.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $7118.0 (down 95.64% YoY) and the FY2025 annual result came in at $6644.0, down 95.84% from the prior year.
- Capital Expenditures slipped to $2321.0 in Q2 2026, from $2411.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $157015.0 in Q4 2024 to a low of -$1580.0 in Q4 2023.
- A 5-year average of $13175.9 and a median of $2087.0 in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures slumped 113.02% — and 2024, when it surged 10037.66%.
- Tracing PBSV's Capital Expenditures over 5 years: stood at $12137.0 in 2022, then slumped by 113.02% to -$1580.0 in 2023, then surged by 10037.66% to $157015.0 in 2024, then slumped by 99.78% to $350.0 in 2025, then soared by 563.14% to $2321.0 in 2026.
- The last three Capital Expenditures figures came in at $2321.0 (Q2 2026), $2411.0 (Q1 2026), and $350.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 1.75 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 29.03 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 15.93 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 1.59 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 1.73 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 56.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 16.11 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 2.32 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 2,321.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2,321.00 |
| Apr 30, 2026 | 2,321.00 |
| Jan 31, 2026 | 2,411.00 |
| Jan 31, 2026 | 2,411.00 |
| Oct 31, 2025 | 350.00 |
| Oct 31, 2025 | 350.00 |
| Jul 31, 2025 | 2,036.00 |
| Jul 31, 2025 | 2,036.00 |
| Apr 30, 2025 | 4,258.00 |
| Apr 30, 2025 | 4,258.00 |
| Oct 31, 2024 | 157,015.00 |
| Oct 31, 2024 | 157,015.00 |
| Jul 31, 2024 | 1,908.00 |
| Jul 31, 2024 | 1,908.00 |
| Jan 31, 2024 | 820.00 |
| Jan 31, 2024 | 820.00 |
| Oct 31, 2023 | -1,580.00 |
| Oct 31, 2023 | -1,580.00 |
| Apr 30, 2023 | 764.00 |
| Apr 30, 2023 | 764.00 |